ARVINAS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
ARVINAS, INC. (ARVN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-04
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.00M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.10M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.30M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.50M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.10M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.30M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.50M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.70M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.80M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $1.60M 10-K · filed 2025-02-11 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-30 |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-30 |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $100.00K 10-K · filed 2024-02-27 |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $200.00K 10-K · filed 2023-02-23 |
| 2022-09-30 | $200.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $200.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $300.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $200.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $218.79K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $362.98K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $399.22K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $204.53K 10-K · filed 2021-03-01 |
| 2020-09-30 | $143.03K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $174.47K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $211.58K 10-Q · filed 2020-04-28 |
| 2019-12-31 | $196.04K 10-K · filed 2020-03-16 |
| 2019-09-30 | $204.98K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $282.89K 10-Q · filed 2019-08-05 |
| 2019-03-31 | $282.89K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |